Skip to main content
TB-500Peptides

For research use only. Not for human consumption. TB-500 is not approved by the FDA for human use and is sold as a research chemical. Not medical advice.

Summaries of published research, cited to the source

TB-500 Peptide Research Guide

What TB-500 (a thymosin beta-4 fragment) is, what cell, animal and early human studies actually show, its safety unknowns, and its FDA and WADA status.

TB-500 is not approved by the FDA for human use and is sold only as a research chemical. We separate preclinical findings from human evidence and never give dosing advice for people.

TB-500 at a glance

What it is
Synthetic peptide based on the actin-binding region of thymosin beta-4 (Tβ4)
FDA status
Not approved for any human use
Sold as
Research chemical, “not for human consumption”
Human evidence
Limited; small trials used full-length Tβ4, not TB-500
Sport
Prohibited by WADA (class S2)

TB-500 vs TB4 (Thymosin Beta-4): The Short Answer

TB4 is the full protein; TB-500 is the fragment built from it. Thymosin Beta-4 (TB4, Tβ4) is a naturally occurring 43-amino acid protein present in nearly every cell in the body. TB-500 is a synthetic 7-amino acid peptide — amino acids 17-23 of that protein — manufactured because it carries the actin-binding activity researchers care about, without the cost of producing the full-length molecule.

They are related, not identical. TB-500 shares TB4's core actin-regulation mechanism, but not every downstream effect attributed to full-length TB4 has been demonstrated for the fragment specifically — and because "TB-500" is a commercial name rather than a standardized one, some suppliers use it loosely for either molecule. If you're comparing the two for research purposes, the sequence on the certificate of analysis matters more than the name on the label.

Read the Full TB-500 vs TB4 Comparison →

Understanding TB-500

🔬

Research-Based

Information grounded in published studies on thymosin beta-4 and its synthetic fragments, referencing real scientific literature.

💊

Study-reported doses

How published studies reported dose, route, and timing, and why those figures are research context rather than instructions for people.

⚖️

Safety & Comparisons

Honest safety profiles, side effect research, and head-to-head comparisons with other peptides like BPC-157.

Latest Articles

View All →
TB-500Thymosin Beta-4Peptide Guide

What Is TB-500? Thymosin Beta-4 Fragment Guide

What TB-500 is, how the synthetic fragment differs from full-length thymosin beta-4, and where the published evidence is still thin.

Aug 7, 202612 min read
TB-500mechanism of actionthymosin beta-4

TB-500 Mechanism of Action: Actin and Angiogenesis

How TB-500 research describes actin binding, cell migration, angiogenesis, and inflammation. Most of the evidence is from cells and animals.

Mar 2, 202629 min read
TB-500Side EffectsSafety

TB-500 Side Effects and Safety: What Is Known

What published research and case discussion actually show about TB-500 side effects, theoretical risks, and unstudied drug combinations.

Feb 26, 202613 min read
TB-500tendon repairtendon healing

TB-500 Tendon, Ligament, and Joint Research

What tendon, ligament, and joint research on thymosin beta-4 covers. No specific injury listed here has a controlled TB-500 trial in people.

Mar 5, 202623 min read

Frequently Asked Questions

Is TB-500 the same thing as TB4 (Thymosin Beta-4)?

No. Thymosin Beta-4 (TB4 or Tβ4) is the full 43-amino acid protein made naturally in nearly every human and animal cell. TB-500 is a synthetic peptide built from just the active fragment of that protein — amino acids 17-23, the region responsible for actin binding. TB-500 is derived from TB4 and shares its core mechanism, but the two are not interchangeable in size, research history, or (in some cases) what a vendor actually ships in the vial. See our full breakdown for the exact differences.

What is TB-500?

TB-500 is a synthetic peptide fragment of thymosin beta-4 (Tβ4), a naturally occurring 43-amino acid protein found in nearly all human and animal cells. It plays a key role in tissue repair, cell migration, and inflammation regulation. TB-500 specifically consists of the active region of Tβ4 (amino acids 17-23) responsible for actin binding and cell motility.

How does TB-500 work?

TB-500 works primarily by upregulating actin, a cell-building protein essential for tissue repair. It promotes angiogenesis (new blood vessel formation), reduces inflammation, and enhances cell migration to injury sites. Research suggests it activates satellite cells in muscle tissue and promotes keratinocyte migration for wound healing.

What is the difference between TB-500 and BPC-157?

While both are healing peptides, they work through different mechanisms. TB-500 primarily promotes systemic healing through actin regulation and cell migration, while BPC-157 works locally through growth factor modulation and gut-healing properties. Combinations are often discussed online, but there are no controlled human studies showing the pair is safe or more effective together.

Is TB-500 legal?

TB-500 is not approved by the FDA for human use. In the U.S. it is marketed only as a research chemical labeled not for human consumption, and FDA has flagged thymosin beta-4 fragments as raising safety concerns for pharmacy compounding. It is prohibited by WADA and most sports bodies. Rules vary by country, so check local law.

What does research say about TB-500 for healing?

Published research in journals like the Annals of the New York Academy of Sciences and FASEB Journal has shown thymosin beta-4 promotes wound healing, reduces inflammation, and supports cardiac tissue repair in animal models. The peptide has demonstrated promise for tendon, ligament, muscle, and skin repair in preclinical studies.

Where to Buy Research-Grade TB-500

The buy guide covers vendor checks, COAs, and red flags. It links to a real research-peptide source. TB-500 is not FDA-approved for human use and is sold for laboratory research only.

Read Where to Buy TB-500 →
🔬

Get the Latest Peptide Research

New dosage guides, study breakdowns, and protocol updates — delivered to your inbox. No spam, unsubscribe anytime.